"Le Centre Hospitalier de Bourg-en-Bresse (CHB) est un établissement de Médecine-Chirurgie-Obstétrique qui compte plus de 900 lits et places, plus de 2 419 professionnels répartis au sein de ses 7 pôles d’activités médicales : Médecine, Chirurgie, Cancérologie, Soins Critiques, Mère-Enfant, Transversal & Support et Gériatrie. Chaque année, le CHB gère également près de 300 000 appels entrants au SAMU 01, plus de 137 000 consultations (hors imagerie, CSP, urgences), plus de 47 000 passages aux Urgences, plus de 12 000 patients sont reçus au bloc opératoire. 120 résidents sont accueillis en USLD et 169 en EHPAD. www .ch-bourg-en-bresse.fr LinkedIN : Centre hospitalier de Bourg-en-Bresse"

During the past decade, Centre Hospitalier Fleyriat; Oncologie/Hematologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" are "Breast Cancer" (5 trials), "Colorectal Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (4 trials), "Pertuzumab" (2 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Fleyriat; Oncologie/Hematologie" are 6 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier Fleyriat; Oncologie/Hematologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centre Hospitalier Fleyriat; Oncologie/Hematologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Fleyriat; Oncologie/Hematologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".